International Arthritis Review Confirms Natural Therapy Benefits for Pain Relief
An international research review has revealed that chondroitin sulfate may help to reduce pain for arthritis sufferers.
The 2015 Cochrane review of international research trials found chondroitin, alone or in combination with glucosamine, was better than placebo in improving pain in people with mild osteoarthritis.
Osteoarthritis affects more than 1.8 million people in Australia and costs the country more than $2.03 billion every year.
Osteoarthritis is a disease of the joints where the joint loses cartilage, the bone grows to try to repair the damage, but this bone growth may make the situation worse. This can make the joint painful and unstable, which can affect physical function or ability to use the joint.
BioCeuticals Education Manager Belinda Reynolds said chondroitin works by helping to slow down the degradation of cartilage and restoring lost cartilage. It also contains amino acids which are essential building blocks for cartilage molecules in the human body.
Ms Reynolds said the extensive Cochrane review examined 43 studies on chondroitin involving 9,110 people.
“It showed that chondroitin reduces knee pain by 20 per cent and slows down the narrowing of joint space width on X-rays of the affected joint,” Ms Reynolds said.
“People who took chondroitin also had pain scores 10 per cent lower than those who took a placebo.
“Those who took chondroitin rated their pain at 18 on a 0 to 100 scale after 6 months while those who took a placebo rated their pain at 28 out of 100.
Ms Reynolds said it was important to take the most effective form of chondroitin supplements at the right dosage.
“New to the Australian market is a form of chondroitin called Bioiberica’s BioActive® chondroitin sulfate which was used as the basis for the USP monograph on chondroitin, a testament to its purity and quality profile,” she said.
“It is the most well researched chondroitin sulfate on the market and is available in supplements prescribed by health practitioners.”
“For example, BioCeuticals new Chondroitin BioActive is a unique combination of Bioiberica’s CS BioActive® chondroitin sulfate and Boswellia serrata standardised to 30% acetyl-11-keto-beta-boswellic acid (AKBA). With a therapeutic one-a-day dose, Chondroitin BioActive provides 800mg of chondroitin.
“Chondroitin BioActive is a professionally prescribed supplement that has sound scientific evidence and may help in slowing the progression of mild osteoarthritis of the knee, and provide temporary relief of symptoms including joint swelling, pain and reduced mobility,” Ms Reynolds said.
“This combination may help to slow the progression of cartilage wear and joint space narrowing, relieve pain and symptoms associated with mild osteoarthritis and temporarily relieve swollen, aching joints and joint inflammation associated with mild arthritis.”
ABOUT BIOCEUTICAL CHONDROITIN BIOACTIVE
Clinically Trialled Ingredients for Joint Pain and Swelling.
A unique combination of Bioiberica’s CS BioActive® chondroitin sulfate and Boswellia serrata standardised to 30% acetyl-11-keto-beta-boswellic acid (AKBA). Chondroitin BioActive may help slow the progression of mild osteoarthritis of the knee, as well as provide temporary relief of symptoms including joint swelling, pain and reduced mobility.
Key features and benefits
- Contains scientifically validated Bioiberica’s CS BioActive® chondroitin sulfate and a highly standardised extract of Boswellia serrata (standardised to 30% AKBA) at therapeutic doses per tablet.
- Provides 800mg of chondroitin and not less than (NLT) 30% AKBA per one-a-day dose.
- Provides nutritional support for the maintenance of healthy joint structure and function.
- Helps to slow the progression of cartilage wear and joint space narrowing.
- May relieve pain and symptoms associated with mild osteoarthritis.
- May temporarily relieve swollen, aching joints and joint inflammation associated with mild arthritis.
- May increase joint mobility in mild arthritis.
- May help to provide relief of symptoms of plantar psoriasis in people with concomitant knee osteoarthritis when taken daily for three months.
- Therapeutic one-a-day dose.
BioCeuticals is at the forefront of evidence-based Integrative Medicine, being a proud sponsor of 6 key clinical trials in primary healthcare facilities. BioCeuticals is committed to helping educate healthcare professionals on research and its practical application for better outcomes for their patients.
Renowned for manufacturing and delivering premium quality integrative medicines to healthcare practitioners, BioCeuticals aims to consistently raise the standards of natural-based therapies.
BioCeuticals is a proud advocate of Corporate Social Responsibility initiatives, with a CSR Committee tasked with ensuring that activities within the company are community-focused and give back where they can.
Speak to your healthcare practitioner to choose the right supplement. Always read the label and use only as directed. If symptoms persist, see your healthcare practitioner.
Stockists: 1300 650 455 or visit www.bioceuticals.com.au
i Singh JA, Noorbaloochi S, MacDonald R, et al. Chondroitin for osteoarthritis. Cochrane Database Syst Rev 2015;1:CD005614. http://www.ncbi.nlm.nih.gov/pubmed/25629804